Article · 2 Jun 2026
Conference abstract
Ethical issues in cell and gene therapy using CRISPR/Cas9 system
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The CRISPR/Cas9 system has revived many safety issues regarding organisms and living systems such as environmental pollution, ecological calamity, risk assessment and genome editing in germline. The new concern is the simplicity, rapidity, accuracy and economics of CRISPR/Cas9 for cell and gene therapies, with the possibility of ethical issues. These issues may include balance of benefits and risks, compatibility of private interests and the public good, random manipulation of genes, and commercialization of human therapy. CRISPR/Cas9 has multiple advantageous applications, but hazards are unavoidable. A scientific evaluation system is needed to assure that benefits are greater than risks. There have been many disputes and frictions among companies over patenting CRISPR/Cas9 for human therapy because many commericial interests are involved. An agreement to regulate patent holders and licensees to consider the public goods is required. Altering a gene may produce new or undesired species, and lead to unknown or unpredictable diseases. The use of CRISPR/Cas9 in gene editing should be deliberately evaluated and strictly controlled, especially in human germline. CRISPR/Cas9 has been demonstrated, promising many disease treatments; however, cell and gene therapies usually require a long course of treatment and cost much. The therapy should be affordable for all patients. Ethics should never be a barrier to science, but allow it to develop in the longterm. It is necessary to have public opinion over the social, legal and ethical implications with the policy/regulatory needs of the system.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Stem Cell Research & Therapy.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Yuan-Chuan Chen”
- BylineArticles whose byline prints “Hui-Fang Li”

